Ciliary Neurotrophic Factor (CNTF) Phase I Trial for Human Retinal Degenerations. In The 35th Annual Meeting for the Society for Neuroscience. presented at the 12/11/2005, Washington, DC.. (2005).
Phase I Study of Ciliary Neurotrophic Factor (CNF) Delivered By Intravitreal Implant of Encapsulated Cell Technology (ECT) Device in Patients with Retinitis Pigmentosa. In The 2005 Annual Association for Research and Vision in Ophthalmology. presented at the 01/05/2005, Ft. Lauderdale, FL.. (2005).
Ciliary Neurotrophic Factor (CNTF) For Human Retinal Neurodegeneration: Phase I Trial of CNTF Delivered by Encapsulated Cell Intraocular Implants. Proceedings of the National Academy of Science, 103, 3896-901. presented at the 2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16505355. (2006).
Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2: Results From a Phase 1 Safety Trial. Am J Ophthalmol, 159, 659-666.e1. presented at the 04/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25528956. (2015).